Dosing flexibility that suits you
3-times-a-week 40 mg/mL
Once-daily 20 mg/mL
The FDA approved Glatopa as a generic medicine that is therapeutically equal to and can be substituted for Copaxone® (glatiramer acetate injection)
Once-daily Glatopa 20 mg/mL was approved in April 2015, and 3-times-a-week Glatopa 40 mg/mL was approved in February 2018.
More days without injections is possible with 3-times-a-week dosing
With the 40 mg/mL dose, you only need to inject 3 times a week. That means you can plan injection-free weekends!